FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151701050> ?p ?o ?g. }

• W2151701050 endingPage "442" @default.
• W2151701050 startingPage "435" @default.
• W2151701050 abstract "Cancer cells reprogram their metabolic pathways to facilitate fast proliferation. Previous studies have shown that overexpression of NF-κB2/p52 (p52) in prostate cancer cells promotes cell growth and leads to castration resistance through aberrant activation of androgen receptor (AR). In addition, these cells become resistant to enzalutamide. In this study, we investigated the effects of p52 activation on glucose metabolism and on response to enzalutamide therapy. Data analysis of gene expression arrays showed that genes including GLUT1 (SLC2A1), PKM2, G6PD, and ME1 involved in the regulation of glucose metabolism were altered in LNCaP cells overexpressing p52 compared with the parental LNCaP cells. We demonstrated an increased amount of glucose flux in the glycolysis pathway, as well as the pentose phosphate pathway (PPP) upon p52 activation. The p52-overexpressing cells increase glucose uptake and are capable of higher ATP and lactate production compared with the parental LNCaP cells. The growth of p52-overexpressing cells depends on glucose in the culture media and is sensitive to glucose deprivation compared with the parental LNCaP cells. Targeting glucose metabolism by the glucose analog 2-deoxy-d-glucose synergistically inhibits cell growth when combined with enzalutamide, and resensitizes p52-overexpressing cells to enzalutamide treatment. These results suggest that p52 modulates glucose metabolism, enhances glucose flux to glycolysis and PPPs, thus facilitating fast proliferation of the cells. Co-targeting glucose metabolism together with AR axis synergistically inhibits cell growth and restores enzalutamide-resistant cells to enzalutamide treatment." @default.
• W2151701050 created "2016-06-24" @default.
• W2151701050 creator A5012734277 @default.
• W2151701050 creator A5028546502 @default.
• W2151701050 creator A5048369552 @default.
• W2151701050 creator A5050196545 @default.
• W2151701050 creator A5053524348 @default.
• W2151701050 creator A5070199787 @default.
• W2151701050 date "2014-03-21" @default.
• W2151701050 modified "2023-10-16" @default.
• W2151701050 title "Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells" @default.
• W2151701050 cites W1589421810 @default.
• W2151701050 cites W1870863388 @default.
• W2151701050 cites W1964353872 @default.
• W2151701050 cites W1967980682 @default.
• W2151701050 cites W1987531976 @default.
• W2151701050 cites W1988924112 @default.
• W2151701050 cites W1995444593 @default.
• W2151701050 cites W2003955264 @default.
• W2151701050 cites W2005381033 @default.
• W2151701050 cites W2005958584 @default.
• W2151701050 cites W2014518336 @default.
• W2151701050 cites W2015207840 @default.
• W2151701050 cites W2021117623 @default.
• W2151701050 cites W2021869596 @default.
• W2151701050 cites W2023033737 @default.
• W2151701050 cites W2028897202 @default.
• W2151701050 cites W2044063668 @default.
• W2151701050 cites W2046265685 @default.
• W2151701050 cites W2046976278 @default.
• W2151701050 cites W2047518382 @default.
• W2151701050 cites W2072451938 @default.
• W2151701050 cites W2085685524 @default.
• W2151701050 cites W2086546138 @default.
• W2151701050 cites W2111642458 @default.
• W2151701050 cites W2111923037 @default.
• W2151701050 cites W2119504728 @default.
• W2151701050 cites W2126127142 @default.
• W2151701050 cites W2131719921 @default.
• W2151701050 cites W2147047620 @default.
• W2151701050 cites W2152530163 @default.
• W2151701050 cites W2162790428 @default.
• W2151701050 cites W2166324735 @default.
• W2151701050 cites W2168277151 @default.
• W2151701050 cites W306915739 @default.
• W2151701050 doi "https://doi.org/10.1530/erc-14-0107" @default.
• W2151701050 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4021715" @default.
• W2151701050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24659479" @default.
• W2151701050 hasPublicationYear "2014" @default.
• W2151701050 type Work @default.
• W2151701050 sameAs 2151701050 @default.
• W2151701050 citedByCount "35" @default.
• W2151701050 countsByYear W21517010502014 @default.
• W2151701050 countsByYear W21517010502015 @default.
• W2151701050 countsByYear W21517010502016 @default.
• W2151701050 countsByYear W21517010502017 @default.
• W2151701050 countsByYear W21517010502018 @default.
• W2151701050 countsByYear W21517010502019 @default.
• W2151701050 countsByYear W21517010502020 @default.
• W2151701050 countsByYear W21517010502021 @default.
• W2151701050 countsByYear W21517010502022 @default.
• W2151701050 countsByYear W21517010502023 @default.
• W2151701050 crossrefType "journal-article" @default.
• W2151701050 hasAuthorship W2151701050A5012734277 @default.
• W2151701050 hasAuthorship W2151701050A5028546502 @default.
• W2151701050 hasAuthorship W2151701050A5048369552 @default.
• W2151701050 hasAuthorship W2151701050A5050196545 @default.
• W2151701050 hasAuthorship W2151701050A5053524348 @default.
• W2151701050 hasAuthorship W2151701050A5070199787 @default.
• W2151701050 hasBestOaLocation W21517010502 @default.
• W2151701050 hasConcept C104317684 @default.
• W2151701050 hasConcept C121608353 @default.
• W2151701050 hasConcept C126322002 @default.
• W2151701050 hasConcept C127561419 @default.
• W2151701050 hasConcept C134018914 @default.
• W2151701050 hasConcept C17093226 @default.
• W2151701050 hasConcept C185592680 @default.
• W2151701050 hasConcept C2776551883 @default.
• W2151701050 hasConcept C2777866211 @default.
• W2151701050 hasConcept C2779306644 @default.
• W2151701050 hasConcept C2779723316 @default.
• W2151701050 hasConcept C2780192828 @default.
• W2151701050 hasConcept C502942594 @default.
• W2151701050 hasConcept C54355233 @default.
• W2151701050 hasConcept C55493867 @default.
• W2151701050 hasConcept C61367390 @default.
• W2151701050 hasConcept C62112901 @default.
• W2151701050 hasConcept C71924100 @default.
• W2151701050 hasConcept C81885089 @default.
• W2151701050 hasConcept C86803240 @default.
• W2151701050 hasConcept C96232424 @default.
• W2151701050 hasConceptScore W2151701050C104317684 @default.
• W2151701050 hasConceptScore W2151701050C121608353 @default.
• W2151701050 hasConceptScore W2151701050C126322002 @default.
• W2151701050 hasConceptScore W2151701050C127561419 @default.
• W2151701050 hasConceptScore W2151701050C134018914 @default.
• W2151701050 hasConceptScore W2151701050C17093226 @default.
• W2151701050 hasConceptScore W2151701050C185592680 @default.

• next